Table 2 Tumor immunophenotypea

From: Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen

 

No recurrence (%)

Recurrence (%)

Total

PTEN (P<0.0001, FET)

 High expression

35 (81.4)

25 (43.9)

60 (60.0)

 Low expression

8 (18.6)

32 (56.1)

40 (40.0)

ER-α (P=0.227, FET)

 High expression

23 (53.5)

23 (40.4)

46 (46.0)

 Low expression

20 (46.5)

34 (59.6)

54 (54.0)

PR (P=0.410, FET)

 High expression

19 (44.2)

20 (35.1)

39 (39.0)

 Low expression

24 (55.8)

37 (64.9)

61 (61.0)

Her-2 (P=0.682, FET)

 High expression

24 (55.8)

35 (61.4)

59 (59.0)

 Low expression

19 (44.2)

22 (38.6)

41 (41.0)

  1. aHigh expression=3+ and 4+, low expression=0–2+.
  2. FET=Fisher's exact test, two-tailed.
Back to article page